CN103142489B - 一种人α-心房肽缓释微球制剂及其制备方法 - Google Patents
一种人α-心房肽缓释微球制剂及其制备方法 Download PDFInfo
- Publication number
- CN103142489B CN103142489B CN201210494722.8A CN201210494722A CN103142489B CN 103142489 B CN103142489 B CN 103142489B CN 201210494722 A CN201210494722 A CN 201210494722A CN 103142489 B CN103142489 B CN 103142489B
- Authority
- CN
- China
- Prior art keywords
- carperitide
- sustained release
- rotating speed
- pva solution
- dissolved
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Landscapes
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210494722.8A CN103142489B (zh) | 2012-11-28 | 2012-11-28 | 一种人α-心房肽缓释微球制剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210494722.8A CN103142489B (zh) | 2012-11-28 | 2012-11-28 | 一种人α-心房肽缓释微球制剂及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103142489A CN103142489A (zh) | 2013-06-12 |
CN103142489B true CN103142489B (zh) | 2014-08-06 |
Family
ID=48541006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210494722.8A Active CN103142489B (zh) | 2012-11-28 | 2012-11-28 | 一种人α-心房肽缓释微球制剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103142489B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106309384B (zh) * | 2015-06-25 | 2019-12-03 | 深圳翰宇药业股份有限公司 | 一种注射用卡培立肽冻干组合物及其制备方法 |
CN109608646B (zh) * | 2018-11-21 | 2021-03-16 | 深圳市孙逸仙心血管医院(深圳市心血管病研究所) | 一种靶向治疗心肌损伤的纳米载体及应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198103B (zh) * | 2011-05-30 | 2014-07-23 | 深圳翰宇药业股份有限公司 | 一种稳定的艾塞那肽缓释微球制剂及制备方法 |
CN102382188B (zh) * | 2011-11-07 | 2014-01-22 | 深圳翰宇药业股份有限公司 | 醋酸卡培立肽的制备方法 |
-
2012
- 2012-11-28 CN CN201210494722.8A patent/CN103142489B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN103142489A (zh) | 2013-06-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6155287B2 (ja) | 機能性pla−peg共重合体、そのナノ粒子、その製造、ならびに標的薬物送達およびイメージングのためのその使用 | |
CN103269690A (zh) | 含有水难溶性药物的缓释聚合物微粒及其制备方法 | |
CN104530256A (zh) | 透明质酸维生素e琥珀酸酯聚合物及其制备和用途 | |
Chen et al. | Self-implanted tiny needles as alternative to traditional parenteral administrations for controlled transdermal drug delivery | |
EP2679227A1 (en) | Nanoparticle containing prostaglandin i2 derivative | |
EP2910242B1 (en) | Durable analgetic sebacoyl dinalbuphine ester-plga controlled release formulation | |
CN103142475B (zh) | 一种醋酸艾塞那肽缓释微球制剂及其制备方法 | |
CN103948911B (zh) | 一种棘白菌素类抗真菌药物缓释微球制剂及其制备方法 | |
EA018203B1 (ru) | Композиция пролонгированного высвобождения, содержащая памоат пасиреотида в микрочастицах с полимерной матрицей, способ получения микрочастиц и способ лечения | |
US8962017B2 (en) | Formulation of silymarin with high efficacy and prolonged action and the preparation method thereof | |
CN1939316B (zh) | 含阿霉素的微球及其制备方法 | |
CN103142489B (zh) | 一种人α-心房肽缓释微球制剂及其制备方法 | |
CN108912349A (zh) | 聚乳酸微球及其制备方法与在药物缓释中的应用 | |
CN103585113B (zh) | 一种芹菜素聚乳酸缓释微球及其制备方法 | |
CN1676121A (zh) | 用于组织、器官局部治疗的缓释微球制剂,及其制备方法和应用 | |
CN102440964A (zh) | 戈舍瑞林缓释微球制剂及其制备方法 | |
CN103142490B (zh) | 一种醋酸奈西立肽缓释微球制剂及其制备方法 | |
CN104436169A (zh) | 戈舍瑞林组合物缓释微球制剂 | |
US20140112957A1 (en) | Analegisic (Sebacoyl dinalbuphine ester) PLGA controlled release formulation form | |
CN103865069A (zh) | 具有生理环境响应功能的主动靶向星形聚合物载体及其制备方法 | |
CN102552169B (zh) | 一种醋酸阿肽地尔缓释微球制剂及其制备方法 | |
CN105997889A (zh) | 一种皮下注射用氨磷汀缓释微球及其制备方法 | |
CN108498485A (zh) | 二氢青蒿素修饰的药物传递载体及其在药学中的应用 | |
JP6560166B2 (ja) | 薬物徐放性担体及びその製造方法 | |
CN101249082B (zh) | 枸橼酸他莫昔芬聚乳酸-羟乙酸共聚物微球的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20130612 Assignee: Shenzhen Xingyin Pharmaceutical Co.,Ltd. Assignor: Shenzhen City Jianyuan Pharmaceutical Technology Co., Ltd. Contract record no.: 2015440020005 Denomination of invention: Human alpha-atrial natriuretic peptide sustained release microsphere preparation and preparation method thereof Granted publication date: 20140806 License type: Exclusive License Record date: 20150109 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20170307 Address after: 518005 Luohu District International Trade Center building, Renmin South Road, Guangdong, Shenzhen, China B11 Patentee after: Shenzhen Xingyin Pharmaceutical Co.,Ltd. Address before: 518057 Nanshan District, Guangdong Province, a high tech in the middle of the road No. ten Shenzhen biological incubation base, building 412, room 2, No. Patentee before: Shenzhen City Jianyuan Pharmaceutical Technology Co., Ltd. |
|
TR01 | Transfer of patent right |